Oncology

A Clinical Study for Stage III Pancreatic Cancer

Choosing to participate in a clinical study is an important personal decision. Please speak with your doctor and/or family members about your options.

If you would like to learn more about the DIRECT study, please call our DIRECT study support line at +1 (800) 584-7608.

or
19 Physicians located who are associated with DIRECT Study.
David A. Iannitti, MD
  • Specialty
    Oncology
  • Location
    1021 Morehead Medical Drive
    Charlotte, NC 28204
  • Phone
    980-442-6410
Physician Website

Physician Bio

Dr. David Iannitti is the Chief of HPB Surgery at Carolinas Medical Center. He specializes in the care of patients with diseases of the liver, pancreas and bile ducts. His surgical interests include minimally invasive liver and pancreas surgery, vascular resections and IRE for advanced pancreas cancer, vena cava tumor removal, and microwave and IRE for liver tumors. Dr. Iannitti attended Dartmouth-Brown medical school, completed his residency at Brown University, and completed his fellowship at The Cleveland Clinic.

Dr. Iannitti has been the Program Director for the HPB Fellowship program, including the research and clinical components, for the past 13 years. He also serves as program director for multiple physician training courses in microwave and radiofrequency ablation as well as a regional/national annual liver course. He has authored more than 80 journal articles and book chapters and more than 150 meeting presentations.

More
Robert C.G. Martin, MD, PhD
  • Specialty
    Oncology
  • Location
    315 E. Broadway
    M10 - Rm#311
    Louisville, KY 40202
  • Phone
    502-629-3355
Physician Website

Physician Bio

Dr. Robert C.G. Martin, MD, PhD, Hepato-Pancreatico-Biliary and Surgical Oncology at the University of Louisville

Dr. Robert C. G. Martin has been a pioneer in IRE clinical use and outcomes. He performed the first case of IRE in the pancreas in 2009 and has performed over 325 cases since then,  He has published over 20 peer review manuscripts in IRE of the pancreas and liver. He is Director of the Division of Surgical Oncology, Department of Surgery, at the University of Louisville School of Medicine. Dr. Martin has been a leader in multidisciplinary cancer patient care and is responsible for many advances at the University of Louisville. His areas of interest include liver tumors (ablations, laparoscopic and open resections), pancreatic, gastric and colon cancers Dr. Robert C.G. Martin, MD, PhD, Hepato-Pancreatico-Biliary and Surgical Oncology at the University of Louisville(laparoscopic and open surgery), esophageal cancer (laparoscopic, open and endoscopic stenting and ablation), bile duct tumors, sarcoma and melanoma. Dr. Martin received his M.D. from the University of Louisville School of Medicine and his surgical oncology training and hepatopancreatic-biliary training from Memorial Sloan-Kettering Cancer Center, and his PhD from the Department of Pharmacology and Toxicology at the University of Louisville School of Medicine.

More
Rebekah R. White, MD, FACS
  • Specialty
    Oncology
  • Location
    3855 Health Sciences Drive
    La Jolla, CA 92093
  • Phone
    858-822-6100
Physician Website

Physician Bio

Rebekah White, MD, is a general surgeon and surgical oncologist who specializes in treating tumors of the pancreas, liver, bile duct, and upper gastrointestinal tract.  Among the procedures she performs are irreversible electroporation (IRE) for pancreatic cancer; Whipple procedure (pancreaticoduodenectomy); laparoscopic distal pancreatectomy and enucleation; pancreas-preserving ampullary and duodenal tumor resection; minimally invasive liver resection; drainage / debridement for chronic pancreatitis; and gallbladder and bile duct tumor resection.

As a surgical oncologist at an academic medical center, Dr. White instructs medical students, residents and fellows at UC San Diego School of Medicine. Her research focuses on novel tests and therapies for earlier detection and improved treatment of pancreatic cancer. Dr. White has published over 50 peer-reviewed articles and also frequently speaks at national medical conferences.

Prior to joining UC San Diego Health, Dr. White was an associate professor in the Department of Surgery at Duke University Medical Center. She completed a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center and a residency in general surgery at Duke University School of Medicine, where she also earned her medical degree.

More
Malcolm M. Bilimoria, MD
  • Specialty
    Oncology
  • Location
    880 West Central Road
    Arlington Heights, IL 60005
  • Phone
    (847) 483-9400
Physician Website

Physician Bio

Dr. Malcolm Bilimoria, MD is a pancreas and hepatobiliary surgeon practicing in Arlington Heights, IL and has been practicing in this capacity for 22 years. He completed his surgical training at Northwestern University in Chicago, IL and his surgical oncology fellowship at MD Anderson Cancer Center in Houston, Texas.

Currently he is the Director of The Illinois Center for Pancreatic and Hepatobiliary Disease, which specializes in treating the pancreas, liver and bile duct cancers. Dr. Bilimoria has performed more than 2500 complex pancreas and liver surgeries.


More
Debashish Bose, MD, PhD, FACS
  • Specialty
    Oncology
  • Location
    1400 South Orange Ave.
    Orlando, FL 32806
  • Phone
    321-841-3508
Physician Website

Physician Bio

Debashish Bose, MD, PhD, is the Director of the Pancreas Center at Orlando Health UF Health Cancer Center.  He is also the chief of GI Surgical Oncology in the Gastrointestinal Cancer Specialty Section at Orlando Health UF Health Cancer Center.  Dr. Bose is board-certified in general surgery and holds a specialty certificate in surgical oncology. He specializes in surgery of the pancreas, liver, stomach and upper abdomen.  Dr. Bose has been part of the center’s Multidisciplinary GI Oncology team since 2010.  Since then, Orlando Health UF Health Cancer Center has developed into a high-volume specialist center for cancers of the pancreas and liver.  Dr. Bose and his colleagues have also developed specialized programs such as the Borderline Resectable program for pancreatic cancer and liver resection for metastatic neuroendocrine cancers.

Dr. Bose graduated from Princeton University, after which he attended the University of Maryland School of Medicine for medical school and graduate school.  He completed his residency in general surgery at the Johns Hopkins Hospital. Dr. Bose then completed the fellowship in surgical oncology at The University of Texas MD Anderson Cancer Center in Houston.  As a recipient of the Ruth L. Kirschtein National Research Service Award in Cancer Research, Dr. Bose also completed his postdoctoral research fellowship in cancer biology. 

More
Steven Curley, MD
  • Specialty
    Oncology
  • Location
    520 E Douglas Blvd
    Tyler, TX 75702
  • Phone
    903-606-4300
Physician Website

Physician Bio

Dr. Curley is the Oncology Institute Director and Chief of Surgical Oncology at CHRISTUS Trinity Mother Frances Hospital in Tyler, TX.  He was previously a Professor and Chief of Surgical Oncology at Baylor College of Medicine in Texas as well as a Professor in Nano- Materials Science at Rice University in Houston, Texas. He received his M.D. from University of Texas Medical School, completed his Surgical Oncology training at The University of Texas - MD Anderson Cancer Center, Houston, and completed his surgical residency at University of New Mexico Hospitals, Albuquerque, NM.  

Dr. Curley’s clinical duties involve providing surgical care for patients with hepatobiliary and gastrointestinal malignancies. When Dr. Curley is not operating on patients, consulting or seeing patients for follow up visits, he spends his time on clinical and laboratory research. His research involves design, bench testing, preclinical testing, and then clinical testing of several new medical devices, including radio frequency ablation of liver tumors. The laboratory combines physics, chemistry, molecular biology, and bioengineering to produce a state-of-the-art approach to novel cancer treatment. 

More
Darius Desai, MD, FACS
  • Specialty
    Oncology
  • Location
    1600 St. Luke’s Blvd
    Easton, PA 18045
  • Phone
    484-503-4600
Physician Website

Physician Bio

Dr. Desai currently serves as the Section Chief of Surgical Oncology for St. Luke’s University Health Network. He is also the cancer liaison for the physician program at St. Luke's University Health Network.

He provides surgical care to patients with complex oncologic needs including patients with pancreatic tumors, gastrointestinal tumors, colorectal cancer, soft tissue tumors/ sarcomas and peritoneal surface malignancies, head and neck tumors, and breast cancer. Dr. Desai’s clinical interests include: complex surgical oncology; sarcoma; GIST; colorectal cancer; colon; GI, thyroid; adrenal; HIPEC chemotherapy; endocrine; melanoma; breast; robotic surgery.

Dr. Desai received his medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and completed his fellowship at the Arthur G. James Cancer Center at The Ohio State University.

More
Cataldo Doria, MD, PhD, MBA, FACS
  • Specialty
    Oncology
  • Location
    One Capital Way
    Pennington, NJ 08534
  • Phone
    609 537 6345
Physician Website

Physician Bio

Dr. Doria is the director of the Capital Health Cancer Center.He isa hepato-pancreato-biliary surgeon who has helped develop and introduce a number of innovative procedures to treat cancer patients that were not previously available, including bloodless liver surgery, liver auto-transplantation and robotic-assisted hepato-pancreato-biliary surgery.

Dr. Doria received his medical degree at University of Perugia School of Medicine, where he also completed his internship and residency. He completed a research fellowship and a clinical fellowship at the Pittsburgh Transplantation Institute, part of the University of Pittsburgh School of Medicine in Pittsburgh, PA. Dr. Doria also completed a clinical fellowship in living donor liver transplantation at the Organ Transplantation Center, part of Asan Medical Center in Seoul, South Korea.

Dr. Doria in the late ’90 was part of a joint venture between the University of Pittsburgh Medical Center and the Italian Government.  As a result of that partnership Dr. Doria built from the ground up a multiorgan transplant facility and a cancer center in South Europe making it one of the most successful transplant program and cancer center in Europe. In the mid ’00 Dr. Doria took upon his leadership a distressed transplant program at Jefferson in Philadelphia and he firsthand made it one of the best transplant program and liver cancer center in the Country  

More
Chet Hammill, MD, MCR, FACS
  • Specialty
    Oncology
  • Location
    660 South Euclid Ave
    Saint Louis, MO 63110
  • Phone
    314-273-1809
Physician Website

Physician Bio

Chet Hammill, MD, MCR, FACS, is a board-certified physician and surgeon specializing in Liver, Bile Duct and Pancreas Surgery.  He is an Associate Professor of Surgery at Washington University in St. Louis. 

Dr. Hammill attended college and medical school at the University of Illinois in Urbana-Champaign, graduating with a Master of Science in Aerospace Engineering in 2002 and completing medical school in 2004. He completed his general surgery training at the University of Hawaii in 2009, and subsequently completed a two-year Hepatobiliary and Pancreas Surgery Fellowship at Providence Portland Medical Center in Portland, Oregon. Dr. Hammill also holds a Master of Clinical Research degree from Oregon Health & Science University.

Dr. Hammill actively participates in research and has multiple peer-reviewed publications. His current areas of research include: minimally-invasive and robotic surgery, image-guided surgery, ablation therapies and immunotherapy in liver and pancreas cancer. 

More
Peter Hosein, MBBS
  • Specialty
    Oncology
  • Location
    1475 NW 12th Ave, Suite 3400
    Miami, FL 33136
  • Phone
    305-243-3462
Physician Website

Physician Bio

Dr. Hosein is a clinical researcher focused on Gastrointestinal Cancers at the University of Miami Hospital, FL. He has been the principal investigator for multiple phase I and II clinical trials for patients with liver and pancreatic cancers conducted at the Sylvester Comprehensive Cancer Center. He has also participated as a co-investigator in national phase III clinical trials in pancreatic and colorectal cancers. His primary research interest is in neoadjuvant therapy for patients with localized pancreatic cancer, and novel therapies for metastatic pancreatic cancer.


Dr. Hosein received his medical degree from University of the West Indies in Trinidad, completed his residency at Jackson Memorial Hospital, and his fellowship at UM-JMH Division of Hematology/Oncology.  He sees patients with cancers of the esophagus, stomach, liver, bile ducts, pancreas, small bowel, colon, rectum and anal canal, as well and gastrointestinal neuroendocrine cancers. Dr. Hosein works closely with surgical oncologists, colorectal surgeons, radiation oncologists and interventional radiologists at Sylvester to coordinate multidisciplinary care for patients with gastrointestinal cancers.

More
1

AngioDynamics, the AngioDynamics logo and NanoKnife are trademarks and/or registered trademarks of AngioDynamics, Inc., an affiliate or a subsidiary. © 2020 AngioDynamics, Inc. GL/ON/WP/105 Rev 01 02/20